|Attachment inhibitor progress
May 30, 2004
Last October I participated in a one week phase one study of an attachment inhibitor whose number escapes me. We took high doses for one week. This was the first hiv med I had taken. My t-cells jumped by 200 in that week and the only side effect was that we all slept better. We weren't drowsy, we just slept better. The most current article I can find on the subject is 2 years old. How's the research coming?
| Response from Dr. Young
Thanks for your question, and most importantly, thanks for your participation in the clinical study.
"Attachment" inhibitors are probably best called entry inhibitors-- they come in a variety of names and types at this point; though the CCR5 inhibitors are in the most advanced clinical studies at this point. Schering-Plough's SCH-C and SCH-D are in phase 2 or 3 currently and several other companies have lead compounds. With so many in development, I'd bet that one of them will make it past FDA approval in the next couple of years. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.